Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Samfine Creation Group | SFHG | 3. avr 2025 | 0.67 | -3.64 |
Samsara A | IOT | 3. avr 2025 | 34.11 | -10.24 |
San Juan Basin Royalty Trust Unit | SJT | 3. avr 2025 | 5.25 | -4.02 |
Sana Biotechnology | SANA | 3. avr 2025 | 1.37 | -15.95 |
Sanara MedTech | SMTI | 3. avr 2025 | 29.40 | -2.23 |
Sandisk | SNDK | 3. avr 2025 | 38.26 | 0.00 |
Sandisk | SNDKV | 3. avr 2025 | 50.37 | 0.00 |
SandRidge Energy | SD | 3. avr 2025 | 10.57 | -7.12 |
Sandstorm Gold | SAND | 3. avr 2025 | 7.53 | +0.53 |
Sandy Spring Bancorp | SASR | 3. avr 2025 | 27.95 | 0.00 |
Sangamo Therapeutics | SGMO | 3. avr 2025 | 0.62 | -4.73 |
Sangoma Technologies | SANG | 3. avr 2025 | 4.45 | -0.67 |
Sanmina | SANM | 3. avr 2025 | 69.16 | -10.77 |
Sanofi ADR | SNY | 3. avr 2025 | 54.62 | +1.24 |
Santech ADR | STEC | 3. avr 2025 | 1.31 | -0.76 |
Sanuwave Health | SNWV | 3. avr 2025 | 29.80 | 0.00 |
SAP ADR | SAP | 3. avr 2025 | 264.34 | -2.61 |
Sapiens | SPNS | 3. avr 2025 | 26.66 | -3.62 |
Saratoga Investment New | SAR | 3. avr 2025 | 25.14 | -0.67 |
Sarepta Therapeutics | SRPT | 3. avr 2025 | 58.61 | -6.18 |
Sasol ADR | SSL | 3. avr 2025 | 3.58 | -13.53 |
Satellogic A | SATL | 3. avr 2025 | 3.29 | -9.25 |
SatixFy Communications | SATX | 3. avr 2025 | 1.98 | -1.49 |
Saul Centers | BFS | 3. avr 2025 | 35.68 | -2.03 |
Saul Centers Pref D | BFS-D | 3. avr 2025 | 20.49 | -0.68 |
Saul Centers Pref E | BFS-E | 3. avr 2025 | 19.66 | -1.95 |
Savara | SVRA | 3. avr 2025 | 2.90 | -3.65 |
Saverone 2014 ADR | SVRE | 3. avr 2025 | 3.14 | -13.26 |
Savers Value Village | SVV | 3. avr 2025 | 7.11 | -4.31 |
SB Financial Group | SBFG | 3. avr 2025 | 19.78 | -4.03 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.